Our indicative theme of Covid-19 Testing Shares, which incorporates medical units and diagnostic fi
Our indicative theme of Covid-19 Testing Shares, which incorporates medical units and diagnostic firms which can be concerned in Covid-19 testing – is up by about 69% year-to-date, considerably outperforming the S&P 500 which is up by about 8% over the identical interval. Testing is considered as key to containing the unfold of the Coronavirus pandemic and re-opening the financial system till a secure and efficient vaccine is developed. It’s doubtless that the demand for testing services and products is more likely to rise with the approaching vacation season. For instance, as journey picks up, testing is more likely to be key to bettering confidence for passengers whereas probably serving to to scale back quarantine restrictions. Inside our theme, Quidel (NASDAQ: QDEL) has been the strongest performer gaining about 260% year-to-date, whereas Quest Diagnostics (NYSE:DGX), up about 11%, was the weakest performer. Beneath is a little more about these firms.
Quidel (QDEL) is an organization that sells diagnostic healthcare merchandise together with speedy diagnostic testing options, cellular-based virology assays, and molecular diagnostic methods. The corporate doubled down on the Covid-19 testing over the past two quarters, and its inventory is up a strong 261% this yr.
QDEL
Hologic (HOLX) sells medical units for diagnostics, surgical procedure, and medical imaging. The corporate presently has two molecular diagnostic checks for Covid-19 together with the Panther Fusion and Aptima checks. The inventory is up by about 31% year-to-date.
Abbott Laboratories (ABT) has a various vary of options together with a take a look at referred to as BinaxNOW that gives take a look at ends in 5 minutes and works with out counting on lab tools. The inventory is up by about 29% year-to-date.
Laboratory of America (LH) operates one of many largest medical laboratory networks on the earth. Whereas the corporate’s normal diagnostic enterprise proved a combined bag over the past two quarters as medical doctors’ visits declined because of the pandemic, it has scaled up the capability and accessibility for Covid-19 checks. The inventory is up by 14% year-to-date.
Quest Diagnostics (DGX) is without doubt one of the largest U.S. diagnostics chains that has been impacted by the pandemic, the corporate’s large-scale Covid-19 testing has compensated for this to an extent. The inventory is up by 11% year-to-date.
high-quality portfolio to beat the market
See all Trefis Worth Estimates and Obtain Trefis Knowledge right here
What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Groups | Product, R&D, and Advertising and marketing Groups
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.